(Q33382749)

English

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

scientific article

Statements

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit